Merck, AG201, MCT4, control peptide for AB3550P

General description
A 19 amino acid peptide sequence within the cytoplasmic domain of human MCT4 (1).
Application
For use in blocking the reactivity of AB3550P.

Optimal working dilution must be determined by the end user.
Research Category
Neuroscience
Research Sub Category
Ion Channels & Transporters
Physical form
Liquid in PBS containing 0.1% BSA and 0.1% sodium azide.
Preparation Note
Maintain at -20°C in undiluted aliquots for up to 6 months after date of receipt. Avoid repeated freeze/thaw cycles.
Legal Information
CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany
Disclaimer
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.